Watchlist Price Alert

BioXcel Therapeutics Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.62

-0.07 (-4.14%)

At close: Jun 17, 2025, 3:59 PM

1.61

-0.62%

After-hours: Jun 17, 2025, 07:40 PM EDT

BioXcel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	29.85M	65.22M	193.72M	232.97M	213.12M	32.43M	42.56M	887K	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	87K	87K	925K	3.93M	87K	51K	51K	461K	n/a
Receivables	131K	71K	248K	n/a	n/a	n/a	115K	n/a	n/a
Inventory	679K	1.99M	1.99M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.44M	2.08M	3.84M	956K	3.95M	n/a	n/a	n/a	n/a
Total Current Assets	37.39M	72.14M	202.87M	232.97M	217.06M	34.11M	43.17M	890K	2K
Property-Plant & Equipment	857K	1.47M	2.06M	2.54M	2.78M	2.23M	327K	4K	5K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	944K	1.56M	2.98M	6.47M	2.87M	2.29M	378K	465K	5K
Total Assets	38.34M	73.7M	205.85M	239.44M	219.94M	36.39M	43.55M	1.35M	7K
Account Payables	15.99M	13.65M	10.23M	4.68M	3.98M	4.95M	1.6M	444K	279K
Deferred Revenue	n/a	n/a	n/a	n/a	7.39M	-164K	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	371K	n/a
Other Current Liabilities	516K	163K	6.46M	7.43M	2.07M	1.88M	n/a	n/a	n/a
Total Current Liabilities	22.23M	27.27M	32.9M	16.67M	11.84M	8.47M	4.66M	2.34M	331K
Long-Term Debt	102.51M	100.6M	93.84M	1.1M	1.4M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.7M	1.91M	1.56M	-1.1M	-1.4M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	109.21M	102.94M	96.18M	1.1M	1.4M	1.03M	n/a	n/a	n/a
Total Liabilities	131.44M	130.21M	129.08M	17.77M	13.24M	9.5M	4.66M	2.34M	331K
Total Debt	102.95M	101.38M	94.16M	1.4M	1.64M	1.03M	n/a	371K	n/a
Common Stock	49K	30K	28K	28K	24K	18K	16K	10K	n/a
Retained Earnings	-650.2M	-590.6M	-411.55M	-245.79M	-138.86M	-56.69M	-23.72M	-4.45M	n/a
Comprehensive Income	n/a	n/a	0.00	n/a	n/a	n/a	-18K	-1K	n/a
Shareholders Equity	-93.1M	-56.51M	76.78M	221.67M	206.7M	26.89M	38.89M	-982K	-324K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a